Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Avian Flu”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01086657
What this trial is testing

An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...

Who this might be right for
Influenza A Virus, H5N1 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 64
Testing effectiveness (Phase 2)Study completedNCT02213354
What this trial is testing

H7N9 Mix and Match With MF59 in Healthy Elderly Persons

Who this might be right for
Avian Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 479
Early research (Phase 1)Study completedNCT03014310
What this trial is testing

H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology

Who this might be right for
Avian Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 388
Early research (Phase 1)Study completedNCT01317745
What this trial is testing

H5N1 Mix and Match With MF59

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 270
Large-scale testing (Phase 3)Study completedNCT01379937
What this trial is testing

Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children

Who this might be right for
Influenza
GlaxoSmithKline 520
Testing effectiveness (Phase 2)Study completedNCT02719743
What this trial is testing

A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age

Who this might be right for
Influenza
GlaxoSmithKline 185
Large-scale testing (Phase 3)Study completedNCT01382329
What this trial is testing

H5N1 Vaccine Study in Japanese Adults

Who this might be right for
H5N1 Influenza
Alachua Government Services, Inc. 340
Testing effectiveness (Phase 2)Study completedNCT01910519
What this trial is testing

Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)

Who this might be right for
Influenza A Virus, H5N1 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00812019
What this trial is testing

Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)

Who this might be right for
Influenza
Seqirus 753
Testing effectiveness (Phase 2)Study completedNCT01353534
What this trial is testing

Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine

Who this might be right for
Healthy
Intercell USA, Inc. 276
Testing effectiveness (Phase 2)Study completedNCT00415129
What this trial is testing

Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 600
Early research (Phase 1)Study completedNCT00240903
What this trial is testing

Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 37
Testing effectiveness (Phase 2)Study completedNCT00115986
What this trial is testing

A/H5N1in Adult - Aventis

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 452
Testing effectiveness (Phase 2)Study completedNCT00537524
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years

Who this might be right for
Prophylaxis of Avian Influenza
Novartis Vaccines 471
Not applicableStudy completedNCT02743676
What this trial is testing

A Retrospective, Observational Registry of Participants With Avian Influenza Infection

Who this might be right for
Influenza
Hoffmann-La Roche 648
Testing effectiveness (Phase 2)Active Not RecruitingNCT07128615
What this trial is testing

A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

Who this might be right for
Influenza A
AstraZeneca 405
Testing effectiveness (Phase 2)Study completedNCT00491985
What this trial is testing

Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children

Who this might be right for
InfluenzaOrthomyxoviridae InfectionsInfluenza A Virus Infection
Sanofi Pasteur, a Sanofi Company 240
Early research (Phase 1)Study completedNCT02206464
What this trial is testing

H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo...

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)Study completedNCT00462215
What this trial is testing

Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 550
Large-scale testing (Phase 3)Study completedNCT00434733
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects

Who this might be right for
Influenza
Novartis 4,400
Next Page